SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $157 | -100.0% | 174,994 | +181.7% | 0.00% | – |
| Q3 2022 | $373,000 | +33.2% | 62,116 | +3.3% | 0.00% | – |
| Q3 2021 | $280,000 | -72.0% | 60,108 | -57.6% | 0.00% | -100.0% |
| Q2 2021 | $1,000,000 | +1036.4% | 141,783 | +849.7% | 0.00% | – |
| Q1 2021 | $88,000 | -50.8% | 14,930 | -67.5% | 0.00% | – |
| Q3 2020 | $179,000 | -13.5% | 45,926 | +538.7% | 0.00% | – |
| Q2 2020 | $207,000 | -60.6% | 7,190 | -79.5% | 0.00% | -100.0% |
| Q3 2019 | $525,000 | – | 35,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |